Company Information & Drug Savings for Ultragenyx Pharmaceutical Medications
Ultragenyx Pharmaceutical is a biopharmaceutical company committed to developing treatments for rare and ultra-rare genetic diseases. Based in Novato, California, the company developed Crysvita (burosumab) for X-linked hypophosphatemia, Mepsevii for MPS VII, and Dojolvi for long-chain fatty acid oxidation disorders. Ultragenyx’s rare disease expertise transforms lives of patients with devastating inherited conditions.
How to Contact Ultragenyx Pharmaceutical
Phone
1-415-483-8800Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
